To better predict the possible in vivo effects of KPL-404, we examined the production of key cytokines, produced by CD40-expressing cells using cell culture supernatants collected from IC- or anti-IgM-stimulated PBMCs from HD, SjS, and SLE patients. This evidence concerns the gene CD40 and Huntington disease.